Clinical Trial Update: Characterization of the Natural History of LAMA2-RD and Identification of Novel Disease Biomarkers

View source ↗

Summary

A clinical trial update detailing characterization of the natural history of LAMA2-related muscular dystrophy (LAMA2-RD) and the identification of novel disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lama2-related Muscular Dystrophy
• Merosin-deficient Congenital Muscular Dystrophy Type 1a

Snippet

Sponsor: Università Vita-Salute San Raffaele | Conditions: LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A), LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\) | Status: RECRUITING